
Philip Katz MD
Advanced Endoscopic Interventional, Esophagus Disease
Clinical Professor of Medicine, Thomas Jefferson University
1283 York AveNew York, NY 10021
Overview of Dr. Katz
Dr. Philip Katz is a gastroenterologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital and NewYork-Presbyterian/Columbia University Irving Medical Center. He received his medical degree from Wake Forest School of Medicine of Wake Forest Baptist Medical Center and has been in practice 48 years. Dr. Katz accepts several types of health insurance, listed below. He is one of 339 doctors at New York-Presbyterian Hospital and one of 138 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center who specialize in Gastroenterology. He has more than 100 publications and over 500 citings.
Education & Training
Wake Forest University Baptist Medical CenterResidency, Internal Medicine, 1979 - 1982
Wake Forest School of Medicine of Wake Forest Baptist Medical CenterClass of 1978
Wake Forest University Baptist Medical CenterFellowship, Gastroenterology
Certifications & Licensure
FL State Medical License 2023 - Present
NY State Medical License 2017 - 2028
PA State Medical License 1996 - 2018
NC State Medical License 1978 - 2002
MD State Medical License 1986 - 1996
NJ State Medical License 1962 - 1993
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
Publications & Presentations
PubMed
- Use of impedance planimetry (325 catheter with 8-cm balloon) improves per-oral endoscopic myotomy outcomes in achalasia patients: a systematic review and a meta-analysis.Muhammad Usman Baig, Zane Gouda, Abhishek Datta Polavarappu, Ali Lahooti, Eliza Cricco-Lizza
Diseases of the Esophagus. 2026-05-12 - PPIs and Dementia: The Final Nail in the Coffin?Colin W Howden, Philip O Katz
Digestive Diseases and Sciences. 2026-05-01 - 22 citationsA Standardized Approach to Performing and Interpreting Functional Lumen Imaging Probe Panometry for Esophageal Motility Disorders: The Dallas Consensus.Dustin A Carlson, John E Pandolfino, Rena Yadlapati, Marcelo F Vela, Stuart J Spechler
Gastroenterology. 2025-06-01
Lectures
- Proton Pump Inhibitors: How to Help Get Your Patients Off of ThemAGC 2018 Annual Scientific Meeting, Philadelphia, PA - 10/9/2018
- GERD – Weighing the Risks and BenefitsAGC 2018 Annual Scientific Meeting, Philadelphia, PA - 10/9/2018
- PPI Risks: Separating Fact From FictionAGC 2018 Annual Scientific Meeting, Philadelphia, PA - 10/7/2018
Press Mentions
Phathom Pharmaceuticals Announces Publication of Data from Phase 3 pHalcon-NERD-301 Study Showing VOQUEZNA® (Vonoprazan) Improved Nocturnal GERD Symptoms in Patients with Non-Erosive Reflux DiseaseOctober 25th, 2025
WATS-3D Biopsy Increases Detection of Barrett’s Esophagus in GERDMarch 25th, 2025
Phathom Pharmaceuticals Announces Positive Topline Results from Phase 3 PHALCON-NERD-301 Trial Evaluating Daily Dosing of Vonoprazan for Symptomatic Non-Erosive Gastroesophageal Reflux Disease (NERD)January 8th, 2023
Professional Memberships
- Member
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
AmeriHealth Direct POS
Amerihealth HMO
AmeriHealth PPO
BCBS Blue Card PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Coventry Carelink Health Plans PPO
First Health PPOGreat West PPO
HealthAmerica HealthAssurance PPO
Horizon BCBS PPO
Humana ChoiceCare Network PPO
IBC Keystone HMO / POS
IBC Personal Choice PPO
Oxford Health Freedom
Oxford Health Liberty
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:






